市场调查报告书
商品编码
1416195
心臟再同步治疗 (CRT) 设备市场 - 按产品(CRT-P、CRT-D)、按年龄(44 岁以下、45-64 岁、65-84 岁、85 岁以上)、最终用途和预测,2023 - 2032Cardiac Resynchronisation Therapy (CRT) Devices Market - By Product (CRT-P, CRT-D), By Age (Below 44 Years, 45- 64 Years, 65-84 Years, Above 85 Years), By End-use & Forecast, 2023 - 2032 |
在医疗技术进步、心臟衰竭盛行率增加以及患者和医疗保健专业人员意识不断提高的推动下,全球心臟再同步治疗(CRT) 设备市场预计在2023 年至2032 年期间将以5.9% 的速度增长。
根据 Radcliffe Cardiology 2023 年发表的一项研究,心臟衰竭 (HF) 是一个不断升级的全球公共卫生问题,影响全球约 6,400 万人。随着人口老化比例的增加以及生活方式因素导致心臟相关问题,对先进心臟护理解决方案的需求变得更加明显。此外,医疗保健专业人员和患者对心臟再同步治疗的好处的认识不断增强,进一步推动了行业的成长。
全球 CRT 设备市场根据产品、最终用途和地区进行分类。
在心臟同步增强、起搏和再同步双重功能以及技术进步的推动下,CRT 起搏器市场预计将在研究期间稳步扩张。双重功能可满足起搏和重新同步需求,使其成为满足心臟护理复杂需求的全面解决方案。此外,对先进心臟护理解决方案不断增长的需求进一步推动了产品需求。
在综合心臟护理服务和能力增强的推动下,心臟护理中心最终用途细分市场将在 2032 年之前获得稳定成长的势头。心臟护理中心优先考虑个人化、以患者为中心的护理,从而提高了它们在医疗保健领域的吸引力。此外,心臟护理中心远距医疗和远端监测技术的整合增强了可近性并改善了患者的治疗效果。
由于心血管疾病发生率不断上升,加上中国和印度等国家医疗基础设施不断扩大,亚太地区心臟再同步治疗设备市场预计将在 2023 年和 2032 年实现强劲成长。该地区的医疗保健行业正在经历快速的技术进步,为该行业创造了有利的环境。此外,由于医疗保健系统专注于改善患者的治疗结果,研发计划的资金将塑造市场前景。
The global Cardiac Resynchronization Therapy (CRT) Devices Market is anticipated to expand at 5.9% during 2023-2032, driven by advancements in medical technology, increasing prevalence of heart failure, and growing awareness amongst patients & healthcare professionals.
According to a study published by Radcliffe Cardiology in 2023, Heart failure (HF) is an escalating global public health concern, affecting an estimated 64 million people worldwide. As the aging population proportion grows and lifestyle factors contribute to heart-related issues, the need for advanced cardiac care solutions becomes more pronounced. Additionally, the growing awareness among healthcare professionals and patients about the benefits of cardiac resynchronization therapy further fuels industry growth.
The global CRT devices market is classified based on product, end-use, and region.
The CRT-pacemakers segment is expected to expand at a steady pace during the study period driven by enhanced cardiac synchronization, dual functionality in pacing & resynchronization and technological advancements. The dual functionality, addressing both pacing and resynchronization needs, positions them as comprehensive solutions for the intricate demands of cardiac care. Moreover, the growing demand for advanced cardiac care solutions has further propelled product demand.
Cardiac care centers end-use segment is gaining momentum for steady growth through 2032, driven by comprehensive cardiac care services and capability enhancement. Cardiac care centers prioritize individualized, patient-centric care, boosting their appeal in the healthcare sector. Moreover, the integration of telemedicine and remote monitoring technologies in cardiac care centers enhances accessibility and improves patient outcomes.
Asia Pacific cardiac resynchronization therapy devices market is set for robust growth during 2023 and 2032, attributed to the increasing incidence of cardiovascular diseases, coupled with the expanding healthcare infrastructure in countries like China and India. The region is witnessing rapid technological advancements in the healthcare sector, creating a conducive environment for the sector. Moreover, as healthcare systems focus on improving patient outcomes, the funding for R&D initiatives will shape the market outlook.